Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269553 | HPB | 2010 | 8 Pages |
Abstract
This pilot study demonstrates the prognostic potential of the PRG, which could be used clinically to select patients for an aggressive multimodal adjuvant algorithm. Larger multicentre studies are required to validate this particular grading system. The keys to longterm survival are resectability and chemo-responsiveness.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Gabriel Chan, Mazen Hassanain, Prosanto Chaudhury, Dionisios Vrochides, Amy Neville, Matthew Cesari, Petr Kavan, Victoria Marcus, Peter Metrakos,